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Abstract
Introduction Bleeding after thyroid and/or parathyroid surgery is a life-threatening emergency. The aim of this study
was to determine the rates of reoperation following bleeding, identify risk factors, assess management strategies and
outcomes, and develop protocols to reduce risk and improve management of bleeding.
Methods A retrospective cohort study of all consecutive patients who underwent thyroid and/or parathyroid surgery
over a 7-year period was conducted. A nested case–control design was used to evaluate specific factors and their
association with reoperation for bleeding.
Results Of 1913 patients, 25 (1.3%) underwent reoperation for bleeding. Of the 25 patients who bled, 6 (24%)
required reoperation before leaving theatre; 17 (68%) had bleeding within 6 h, 1 (4%) between 6 and 24 h, and 1
(4%) after 24 h. Reoperation for bleeding was not associated with age, gender, or surgeon. Patients who had total
thyroidectomy were more likely to have reoperation for bleeding compared to hemithyroidectomy (p = 0.045) or
parathyroidectomy (p = 0.001). The following factors were not associated with bleeding: neck dissection, re-do
surgery, drain use, blood-thinning medication or clotting disorders, and BMI. Patients who had reoperation for
bleeding had longer hospital stay (p = 0.001), but similar rates of RLN palsy, wound infection, and
hypoparathyroidism.
Conclusion A higher risk profile for significant post-operative bleeding cannot be determined in patients undergoing
thyroid surgery. Based on this experience, we developed protocols to reduce the risk of bleeding (the ITSRED Fred
protocol) and for the early detection and management of bleed (the SCOOP protocol) following thyroid and/or
parathyroid surgery.
Introduction
Bleeding after thyroid or parathyroid surgery is a life-
threatening emergency as it has the potential to compro-
mise the airway [1]. Reoperation for bleeding can be
considered an objective way of quantifying rates of sig-
nificant bleeding and has been reported to occur in around
0.07 to 4.2% of such neck operations [1–20].
Identification of risk factors for bleeding may help to
identify patients requiring closer monitoring and guide
development of preventative measures. A Medline search
showed a number of articles directed at incidence and risk
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factors [2–6]; but there are little data on preventative and
management strategies.
Post-thyroidectomy haematoma can potentially lead to
significant morbidity including emergency tracheostomy,
cardiac arrest, stroke, and transient ischaemic attack [3, 4].
Although rare, deaths attributable to post-thyroidectomy
haematoma have also been reported [3–5, 7].
The aim of this study was to determine the incidence of
post-operative bleeding in patients undergoing thyroid or
parathyroid surgery in one tertiary centre, identify risk
factors for bleeding, study bleeding patterns, and evaluate
management strategies and outcomes. In addition, we
sought to devise a preventative algorithm for neck hae-
matoma, and a protocol for early detection and manage-
ment of neck haematoma.
Methods
Study design
This was primarily an observational retrospective cohort
study. In addition, a nested case–control analysis was also
performed to study a few additional risk factors in more
detail. In this analysis, 197 patients were selected randomly
from the non-bleed group, and this was compared to the 25
patients in the bleed group.
Setting
The study was undertaken at Sheffield Teaching Hospitals’
endocrine surgical unit, a tertiary referral site. All patients
who underwent thyroid and/or parathyroid surgery between
January 2010 and March 2017 were included. All opera-
tions were performed or supervised by one of two endo-
crine surgical consultants in the unit; however, four
different consultants were involved in the study period.
Data were collected using a standardised data collection
tool.
Participants
All consecutive patients who underwent thyroid and/or
parathyroid surgery were included. In addition, patients
who underwent lymph node dissection without thyroidec-
tomy/parathyroidectomy were also included. Patients
undergoing excision of thymic cysts or biopsy/excision of
lymph nodes or lipomata in the neck were excluded. Eli-
gible patients were identified using theatre electronic
database.
Variables
The primary outcome was the rate of reoperation for post-
operative bleeding. This was defined by the need for
evacuation of haematoma either as part of the same oper-
ation (after skin closure) or a return to operating theatre.
The following secondary outcomes were evaluated: tran-
sient and permanent recurrent laryngeal nerve (RLN) palsy,
transient and long-term hypoparathyroidism, and culture-
proven wound infection. RLN palsy was confirmed on
post-operative laryngoscopy. This was considered transient
if the patients’ voice returned completely to normal or the
patient had a normal repeat vocal cord check at subsequent
follow-up. Transient hypoparathyroidism was defined as
post-operative day one corrected calcium less than
2.10 mmol/L. Long-term hypoparathyroidism was defined
as the need for calcium and/or vitamin D supplements to
maintain normocalcaemia at 6 months or more after
surgery.
In the entire cohort, factors such as age, gender, and
primary organ of surgery were compared between those
who underwent reoperation for bleeding and those who did
not. The following factors were also evaluated as part of a
nested case–control study, as described previously: primary
surgery, neck dissection, re-do surgery, drain use, blood-
thinning medication use or clotting disorder, RLN palsy,
wound infection, hypoparathyroidism, BMI, and length of
stay.
Data collection and analysis
Data were collected from electronic patient databases
(theatre databases, electronic reporting, electronic case
notes and letters) into a Microsoft ExcelTM spreadsheet. No
formal sample size calculations were done as all consecu-
tive patients within the defined inclusion period were
included. The data were anonymised and transferred to
SPSS for analyses. Categorical data were reported as fre-
quencies. Parametric data were reported as mean and
standard deviation, and nonparametric data as median and
interquartile range. The association between variables and
post-operative haematoma was analysed with Chi-squared
test (or Fishers’ exact) for categorical variables, and
independent sample t test for (or Mann–Whitney U test) for
continuous variables. A p value of\ 0.05 was considered
to be statistically significant.
Approval from the study was obtained from the clinical
effectiveness in Sheffield Teaching Hospitals (Ref No.
9635). As this was an observational study, a formal ethics
application was not deemed to be necessary and individual
patient consent was not obtained. All data were initially
stored in password-protected NHS computers, and patient
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identifiable data were removed prior to analyses and
reporting.
Results
A total number of 1913 procedures were performed. The
operations were as follows: 1253 (65.5%) thyroid surgery,
613 (32%) parathyroid surgery, and 47 (2.5%) concomitant
thyroid and parathyroid surgery. There were 1454 (76%)
female and 459 (24%) male patients, with a median age of
53 (i.q.r. 27) years.
Of the 1913 procedures, 25 (1.3%) patients had reop-
eration for bleeding. The rates were 1.8% (23/1253) in
thyroid surgery, 0.3% (2/613) in parathyroid surgery, and
0% (0/47) in patients who had both thyroid and parathyroid
surgery. Patients who underwent thyroidectomy were more
likely to have reoperation for bleeding compared to those
that underwent parathyroidectomy (p = 0.008). The con-
sultant involved, age of the patient at surgery, and patient
gender were not associated with reoperation for bleeding
(Table 1).
Further analyses were performed as part of the nested
case–control study. We compared the 25 patients who had
reoperation for bleeding to 197 randomly selected patients
with no bleeding (see Table 2). Patients who had total
thyroidectomy were more likely to have reoperation for
bleeding compared to hemithyroidectomy (p = 0.045) or
parathyroidectomy (p = 0.001). Patients who had reopera-
tion were significantly more likely to have a longer hospital
stay (p = 0.001).
Table 3 shows the management strategies in the 25
patients who had reoperation for bleeding. In 23 patients
(92.0%), bleeding occurred either in the operating theatre
after skin closure or less than 6 h after surgery. The man-
agement included removal of neck sutures on the ward (or
post-anaesthesia care unit) prior to definitive exploration in
6/19 (31.6%) and steroid administration in 12/19 (63.2%).
The source of bleeding was clearly identifiable in 16/25
(64.0%) of patients. A neck drain was used after explo-
ration for bleeding in 18/25 (72.0%) patients, and 8/25
(32.0%) patients were monitored in high-dependency unit
following surgery. One patient required blood transfusion.
There was no post-operative mortality or need for tra-
cheostomy in the cohort of patients who underwent re-
operative surgery for bleeding.
Discussion
Incidence and risk factors for bleeding after thyroid
and/or parathyroid surgery
This study examined the incidence and risk factors for
significant bleeding (defined as need for reoperation) fol-
lowing thyroid and parathyroid surgery. The management
of patients with significant bleeding and their clinical
outcomes have also been described. We also included
patients who had bleeding in theatre after skin closure. The
reoperation rate for bleeding in our unit was 1.3%. This
falls within the range reported in the literature (0.07 to
4.2%) [1–20]. Generally, lower rates of reoperation for
bleeding have been reported in patients undergoing
parathyroid surgery alone (0 to 1.1%) [2, 11, 16, 18, 19] or
when rates in parathyroid surgery and thyroid surgery are
pooled (0.4 to 0.8%) [2, 11, 16, 19].
We found that total thyroidectomy significantly increa-
ses the risk of reoperation for bleeding compared to
hemithyroidectomy and parathyroidectomy. This is in
keeping with other reports [4, 21]. Furthermore, other
studies have identified older age [4, 5, 21], male gender
[4, 5, 21], antithrombotic medication [21], bleeding disor-
ders [5], neck dissection [21], and re-do operation [4, 21] as
risk factors for bleeding. These variables were not associ-
ated with bleeding in our cohort.
The use of haemostatic agents in our cohort was variable
and was not systematically documented in the operative
notes, so we did no evaluate this. Other studies have found
no effect in the rates of bleeding with the use haemostatic
gel [22], oxidised cellulose patch [23], and fibrin sealant
(TachoSil) [24].
Table 1 Association between clinical characteristics and reoperation
for bleeding for whole cohort
Characteristics Reoperation for bleeding p value
Yes (25) No (1888)
Age, median (i.q.r.) 52 (35) 53 (26) 0.986
Gender
Female 18 (1.2%) 1436 (98.8%) 0.639
Male 7 (1.5%) 452 (98.5%)
Primary organ of surgery
Thyroid 23 (1.8%) 1230 (98.2%) 0.017
Parathyroid 2 (0.3%) 611 (99.7%)
Both thyroid and parathyroid 0 (0%) 47 (100%)
Consultants
A 13 (1.5%) 840 (98.5%) 0.255
B 8 (0.9%) 874 (99.1%)
C 4 (2.6%) 147 (97.4%)
D 0 (0%) 27 (100%)
i.q.r., interquartile range
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Prevention of bleeding after thyroid and/
or parathyroid surgery
In our study, six patients had bleeding whilst in theatre
after wound closure. We found clear sources of bleeding in
five of these patients (arterial/venous/thyroid bed). This can
be attributed to many factors including inadequate
haemostasis; slippage of clips/knots as a result of increased
venous pressure from coughing/retching at extubation or
elevated blood pressure at extubation. This experience has
led us to develop an intraoperative protocol to prevent
bleeding (ITSRED Fred) (Table 4). The protocol includes
practical steps to identify bleeding points prior to wound
closure: irrigation with water to remove blood clots and
Table 2 Association between clinical characteristics and reoperation for bleeding in the nested case–control study
Characteristics Reoperation for bleeding p value
Yes (25) No (197)
Index procedure
TT 16 (64.0%) 60 (30.5%) 0.006
HT 7 (28.0%) 68 (34.5%)
Parathyroidectomy 2 (8.0%) 66 (33.5%)
Others 3 (1.4%) 3 (1.5%)
Neck dissection
Yes 2 (8.0%) 15 (7.6%) 1.000
No 23 (92.0%) 182 (92.4%)
Re-do surgery
Yes 1 (4.0%) 14 (7.1%) 1.000
No 24 (96.0%) 183 (92.9%)
Drain usec
Yes 3 (12.5%) 16 (8.1%) 0.442
No 21 (87.5%) 181 (91.9%)
Any blood-thinning drugs or clotting disorderc
Yes 2 (8.3%) 24 (12.2%) 0.747
No 22 (91.7%) 173 (87.8%)
RLN palsyc
None 20 (95.2%) 177 (94.7%) 0.699
Transient 0 (0%) 4 (2.1%)
Permanent 1 (4.8%) 6 (3.2%)
Wound infection
Yes 0 (0%) 2 (1.0%) 1.000
No 25 (100%) 195 (99.0%)
Hypoparathyroidismc
None 16 (84.2%) 168 (92.3%) 0.184
Transient 1 (5.3%) 9 (4.9%)
Long term 2 (10.5%) 5 (2.7%)
Significant complication
None 21 (84.0%) 174 (88.3%) 0.422
Transienta 1 (4.0%) 12 (6.1%)
Long termb 3 (12.0%) 11 (5.6%)
BMI, median (i.q.r.) 27 (24-29) 27 (23-31) 0.848
Length of stay after surgery, days, median (i.q.r.) 3 (2-3) 1 (1-2) 0.001
i.q.r., interquartile range; BMI, body mass index
aHypoparathyroidism, RLN palsy, wound infection
bRLN palsy, hypoparathyroidism
cMissing data excluded from analysis; TT, total thyroidectomy; HT, hemithyroidectomy; RLN, recurrent laryngeal nerve
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identify other bleeding points, pause to check for bleeding,
elevation of systolic BP to over 100 mm Hg, relief of neck
extension, elevation of venous pressure (either by a Val-
salva manoeuvre, by ‘head-down’ position or both)
[25–27], use of adjuncts (such as regenerated cellulose)
[25, 26], and a final assessment of bleeding under the flaps.
Management of bleeding after thyroid and/
or parathyroid surgery
Furthermore, during the study period, there was no readily
available formal protocol for use by junior staff for the
management for neck haematoma. Our experience of
managing the 25 patients who had bleeding has led to the
development of a protocol to aid early detection and
management of neck swelling post-thyroid and parathyroid
surgery (Fig. 1). This involves initiating early oxygen
therapy, intravenous hydrocortisone, and immediate
involvement of the surgeon, anaesthetist and lead theatre
nurse. In cases of significant airway compromise and the
absence of trained staff to intubate, removal of sutures and
relieving pressure in the recovery room or surgical ward
serves as a temporising measure before definitive surgical
exploration. Inability to secure the airway via endotracheal
intubation may result in tracheostomy or cricothyroido-
tomy [26].
The occurrence of significant bleeding 6 h after surgery
is cited as a concern in the routine adoption of day case
thyroid surgery [28]. Given most bleeds occur within 24 h
after surgery, some have argued for at least 24 h of
observation [13]. Others have argued that day case thyroid
surgery is feasible with appropriate patient selection,
patient support system, and experienced surgical teams
[19]. Rajeev et al. [19] retrospectively evaluated patients
who underwent day case thyroid and parathyroid surgery.
A total of 163/1326 (12.3%) thyroid surgery and 275/776
(35.4%) parathyroid operations were performed as day
case. None of the day case patients were re-admitted for
bleeding. Based on our experience, parathyroidectomy can
be performed as a day case procedure in appropriately
selected patients given the low rates of reoperation for
bleeding. However, we are unable to stratify risk of reop-
eration for bleeding in thyroid surgery.
Limitations
The limitations of this study primarily include its retro-
spective nature and the biases inherent to these types of
study. However, selection bias was minimised by ensuring
that all consecutive patients within the study period were
included. Any bias in ascertainment of outcomes was
minimised by ensuring that these were defined as objec-
tively as possible and the data were collected indepen-
dently of the operating surgeons. The definition of post-
operative haematoma/bleeding may be variable and sub-
jective; which is why it has been defined as ‘need for
reoperation’ in this study. Given the rarity of the primary
Table 3 Management of 25 patients who had reoperation for
bleeding after thyroid and/or parathyroid surgery
Management characteristics n (%)
Time bleeding identified
In theatre 6/25 (24)
After leaving theatre (B 6 h) 17/25 (68)
6–24 h post-operative 1/25 (4)
[ 24 h 1/25 (4)
Neck suture removed prior to theatrea
Yes 6/19 (31.6)
No 11/19 (57.9)
Unknown 2/19 (10.5)
Steroids givenb
Yes 12/19 (63.2)
No 6/19 (31.6)
NK 1/19 (5.3)
Bleeding pointsc
Pyramidal lobe vessel 1 (4)
Strap muscles/sternocleidomastoid 3 (12)
Thyroid bed 2 (8)
Inferior thyroid artery/branch 3 (12)
Cricothyroid junction 2 (8)
Anterior jugular vein 1 (4)
Superior pole vessel 3 (12)
Superior thyroid vein 1 (4)
Generalised ooze 1 (4)
Ligament of Berry 1 (4)
No specific bleeding point 9 (36)
Imaging done
Ultrasound neckb 1/25 (4)
No imaging 24/25 (96)
Drain use following washout
Yes 18/25 (72.0)
No 7/25 (28.0)
Blood transfusion
Yes 1/25 (4.0)
No 24/25 (96.0)
HDU care after surgery
Yes 8/25 (32.0)
No 17/25 (68.0)
aOnly includes patients who bled after leaving theatre
bOne patient had ultrasound after presenting 4 days post-operative
cTwo cases with multiple bleeding points
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outcome, the analyses of risk factors could be susceptible
to type II error. In addition, missing data on RLN palsy and
hypoparathyroidism in the ‘no bleeding cohort’ limited
assessment of these variables. Although we have developed
protocols for the prevention (Table 4) and management
(Fig. 1) of haematoma following neck surgery, these have
not been validated and their effectiveness is as yet unclear.
Conclusion
The rate of neck haematoma following thyroid and
parathyroid surgery in our unit is comparable to others.
Risk stratification for bleeding in thyroid surgery could not
be achieved based on the results. Further work should
assess the effectiveness of preventative and management
strategies to reduce morbidity of neck haematoma.
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Table 4 ITSRED Fred Protocol for preventing post-surgical neck haematoma after thyroid and/or parathyroid surgery
Parameters
I Irrigation of wound with water—to clear field and look for minor bleeding points [11, 25]
T Time—wait a few minutes
S Systolic blood pressure to be[ 100 mm Hg at time of closure
R Relieve neck extension—either by deflating bag under shoulders, removing sand bag, or flexing the neck
E Elevate venous pressure—either by Valsalva manoeuvre [25, 26], head-down position, or both [27]
D Do not drain it, deal with it and consider sealants such as fibrillar [25, 26]
Fred Flaps—evaluation of bleeding under subplatysmal flaps prior to closure
Fig. 1 SCOOP protocol for neck swelling after thyroid and/or parathyroid surgery
World J Surg
123
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this licence, visit http://creativecommons.
org/licenses/by/4.0/.
References
1. Rosenbaum MA, Haridas M, McHenry CR (2008) Life-threat-
ening neck hematoma complicating thyroid and parathyroid
surgery. Am J Surg 195:339–343
2. Abbas G, Dubner S, Heller KS (2001) Re-operation for bleeding
after thyroidectomy and parathyroidectomy. Head Neck
23:544–546
3. Wojtczak B, Aporowicz M, Kaliszewski K et al (2018) Conse-
quences of bleeding after thyroid surgery—analysis of 7805
operations performed in a single center. Arch Med Sci
14:329–335
4. Promberger R, Ott J, Kober F et al (2012) Risk factors for
postoperative bleeding after thyroid surgery. Br J Surg
99:373–379
5. Weiss A, Lee KC, Brumund KT et al (2014) Risk factors for
hematoma after thyroidectomy: results from the nationwide
inpatient sample. Surgery 156:399–404
6. Sorensen KR, Klug TE (2015) Routine outpatient thyroid surgery
cannot be recommended. Dan Med J 62:A5016
7. Bergamaschi R, Becouarn G, Ronceray J et al (1998) Morbidity
of thyroid surgery. Am J Surg 176:71–75
8. Materazzi G, Dionigi G, Berti P et al (2007) One-day thyroid
surgery: retrospective analysis of safety and patient satisfaction
on a consecutive series of 1571 cases over a three-year period.
Eur Surg Res 39:182–188
9. Lang BHH, Yih PCL, Lo CY (2012) A review of risk factors and
timing for postoperative hematoma after thyroidectomy: is out-
patient thyroidectomy really safe? World J Surg 36:2497–2502
10. Godballe C, Madsen AR, Pedersen HB et al (2009) Post-thy-
roidectomy hemorrhage: a national study of patients treated at the
Danish departments of ENT Head and Neck Surgery. Eur Arch
Otorhinolaryngol 266:1945–1952
11. Dixon JL, Snyder SK, Lairmore TC et al (2014) A novel method
for the management of post-thyroidectomy or parathyroidectomy
hematoma: a single-institution experience after over 4000 central
neck operations. World J Surg 38:1262–1267
12. Segel JM, Duke WS, White JR et al (2016) Outpatient thyroid
surgery: safety of an optimized protocol in more than 1000
patients. Surgery 159:518–523
13. Farooq M, Nouraei R, Kaddour H et al (2017) Patterns, timing
and consequences of post-thyroidectomy haemorrhage. Ann R
Coll Surg Engl 99:60–62
14. Bergenfelz A, Jansson S, Kristoffersson A et al (2008) Compli-
cations to thyroid surgery: results as reported in a database from a
multicenter audit comprising 3660 patients. Langenbecks Arch
Surg 393:667–673
15. Zhang X, Du W, Fang Q (2017) Risk factors for postoperative
haemorrhage after total thyroidectomy: clinical results based on
2678 patients. Sci Rep 7:7075
16. Talutis SD, Drake FT, Sachs T et al (2019) Evacuation of post-
operative hematomas after thyroid and parathyroid surgery: an
analysis of the CESQIP Database. Surgery 165:250–256
17. Perera M, Anabell L, Page D et al (2016) Risk factors for post-
thyroidectomy haematoma. J Laryngol Otol 130(Suppl 1):S20–
S25
18. Tang JA, Salapatas AM, Bonzelaar LB et al (2017) Parathy-
roidectomy for the treatment of hyperparathyroidism: thirty-day
morbidity and mortality. Laryngoscope 128:528–533
19. Rajeev P, Sutaria R, Ezzat T et al (2014) Changing trends in
thyroid and parathyroid surgery over the decade: is same-day
discharge feasible in the United Kingdom? World J Surg
38:2825–2830
20. Friguglietti CU, Lin CS, Kulcsar MA (2003) Total thyroidectomy
for benign thyroid disease. Laryngoscope 113:1820–1826
21. Liu J, Sun W, Dong W et al (2017) Risk factors for post-thy-
roidectomy haemorrhage: a meta-analysis. Eur J Endocrinol
176:591–602
22. Khadra H, Bakeer M, Hauch A et al (2018) Hemostatic agent use
in thyroid surgery: a meta-analysis. Gland Surg 7:S34–S41
23. Amit M, Binenbaum Y, Cohen JT et al (2013) Effectiveness of an
oxidized cellulose patch hemostatic agent in thyroid surgery: a
prospective, randomized, controlled study. J Am Coll Surg
217:221–225
24. Erdas E, Medas F, Podda F et al (2015) The use of a biologic
topical haemostatic agent (TachoSil((R))) for the prevention of
postoperative bleeding in patients on antithrombotic therapy
undergoing thyroid surgery: a randomised controlled pilot trial.
Int J Surg 20:95–100
25. Terris DJ, Snyder S, Carneiro-Pla D et al (2013) American
Thyroid Association statement on outpatient thyroidectomy.
Thyroid 23:1193–1202
26. Harding J, Sebag F, Sierra M et al (2006) Thyroid surgery:
postoperative hematoma—prevention and treatment. Langen-
becks Arch Surg 391:169–173
27. Ozdemir M, Makay O, Icoz G et al (2017) What adds Valsalva
maneuver to hemostasis after Trendelenburg’s positioning during
thyroid surgery? Gland Surg 6:433–436
28. Doran H, England J, Palazzo F (2012) Questionable safety of
thyroid surgery with same day discharge. Ann R Coll Surg Engl
94:543–547
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
World J Surg
123
